Image

Self-compassion and Quality of Life After Dementia Diagnosis

Recruiting
65 years of age
Both
Phase N/A

Powered by AI

Overview

This study aims to investigate whether self-compassion is associated with older adult's quality of life after a diagnosis of dementia, and whether perceived threat posed by dementia mediates this relationship. Self-compassion has been found to be positive in supporting individuals in times of difficulty, in adjustment processes and older adults' wellbeing. While different factors have begun to be identified which are associated with individuals' psychological wellbeing and adjustment following a dementia diagnosis, little is known about the influence of self-compassion.

Participants will be recruited via NHS memory clinics, Join Dementia Research and from the community via third-sector organisations. Individuals will be invited to attend a Microsoft Teams/telephone appointment in which informed consent and cognitive screening processes will take place at the start. Eligible participants will then be invited to continue to complete measures administered by a researcher and an interview question. Participants will be offered the opportunity to complete the measures in a second session (within 8 weeks) or using the online survey software, Qualtrics, if preferred.

A small pilot study (n = 5) will take place prior to the main study.

Eligibility

Inclusion Criteria:

  • An older adult aged ≥ 65 years
  • A confirmed diagnosis of dementia received within the past 12 months
  • They have knowledge of their diagnosis
  • They have English language proficiency
  • They have capacity to give informed consent to participation.

Exclusion Criteria:

  • They are deemed to lack capacity to give informed consent to participate (as per the Mental Capacity Act, 2005).
  • They have a diagnosis of early-onset dementia, defined as individuals who are aged < 65 at diagnosis
  • A score on the MoCA Blind (Nasreddine, 2022b) screening measure of <7 out of 22, which is calculated as equivalent to <10 out of 30 on the MoCA (Nasreddine et al., 2005).

Study details

Dementia

NCT06465173

Oxford Health NHS Foundation Trust

25 June 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.